Table II.
Biochemical and anthropometric data of Mexicans with T2D
| Clinical data | All patients (N = 415) | Women (n = 301) | Men (n = 114) | P-value |
|---|---|---|---|---|
| Age [years] | 57.85 ±11.67 | 57.51 ±11.60 | 58.76 ±11.81 | 0.74 |
| BMI [kg/m2] | 28.52 ±6.54 | 29.13 ±7.19 | 26.95 ±3.85 | < 0.001* |
| Weight [kg] | 68 ±13 | 66 ±13 | 73 ±13 | < 0.001* |
| Height [cm] | 154 ±10 | 151 ±7 | 164 ±9 | 0.014 |
| WHR | 0.91 ±0.07 | 0.89 ±0.07 | 0.95 ±0.06 | 0.565 |
| HIP [cm] | 103 ±13 | 105 ±14 | 100 ±9 | < 0.001* |
| Waist [cm] | 97 ±11 | 97 ±11 | 96 ±11 | < 0.001* |
| SBP [mm Hg] | 133.91 ±22.02 | 134.13 ±22.84 | 133.35 ±19.71 | 0.474 |
| DBP [mm Hg] | 75.17 ±11.42 | 74.51 ±11.69 | 76.92 ±10.48 | 0.8314 |
| Glucose [mg/dl] | 129.08 ±63.52 | 128.92 ±60.90 | 129.52 ±29.96 | 0.8307 |
| Cholesterol [mg/dl] | 191.64 ±40.80 | 196.16 ±41.67 | 180.15 ±35.60 | 0.1274 |
| TRG [mmol/l] | 1.90 (1.42–2.77) | 1.93 (1.46–2.76) | 1.08 (1.19–2.84) | 0.1897 |
| HDL [mg/dl] | 39.39 ±10.89 | 41.20 ±11.16 | 34.96 ±8.39 | 0.0926 |
| Insulin [µIU/ml] | 8.15 ±9.75 | 8.59 ±10.68 | 7.12 ±6.57 | 0.1499 |
| HbA1c (%) | 8.26 ±2.58 | 8.23 ±2.60 | 8.35 ±2.53 | 0.4085 |
| HOMA-IR | 2.47 (1.56–4.33) | 2.65 (1.69–4.49) | 2.26 (1.41–3.72) | < 0.001* |
N – total sample size, n – sub-group size, BMI – body max index, WHR – waist to hip ratio, SBP – systolic blood pressure, DBP – diastolic blood pressure, TRG – triglycerides, HDL – high-density lipoprotein, HbA1c – glycated haemoglobin, HOMA-IR – homeostasis model assessment of insulin resistance. Variables are expressed as means ± SD and median (25th–75th percentile).
*
P-value < 0.05.